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Abstract
Since 1971, when Dr. Francis Fontan and collaborators described a surgical 
technique that restored pulmonary flow in patients with tricuspid atresia and 
despite the fact that it has had modifications over time, the impact on the survival 
of these patients has been notable. It is currently known as the Fontan procedure 
and is indicated to treat single ventricle congenital heart defects. Thanks to the great 
advances in the field of congenital heart surgery, as well as better pediatric cardiol-
ogy and intensive care management, the survival of patients with congenital heart 
defects has increased significantly, among whom are patients with univentricular 
or single ventricle physiology. The objective of this chapter is to provide the anes-
thesiologist with useful and applicable concepts in the evaluation and perioperative 
management of patients with a Fontan repair, especially for noncardiac surgeries.
Keywords: congenital heart disease (CHD), chronic heart failure (CHF),  
single ventricle (SV), Fontan procedure, Fontan physiology, Fontan failure, 
pulmonary vascular resistance (PVR), systemic vascular resistance (SVR),  
total cavopulmonary connection (TCPC), cardiac output (CO), cardiac index (CI), 
preoperative evaluation, intraoperative management
1. Introduction
Univentricular patients in the stage of Fontan palliation have a higher periopera-
tive risk than their counterparts with normal hearts.
The diagnosis and treatment of children with congenital heart disease (CHD) 
has improved significantly over the last decades. The incidence of CHD has 
remained stable; the natural history of the lesions and overall survival rate have also 
changed notably. Advances made in surgical procedures and techniques, in concert 
with improvements in diagnosis, anesthesia practices, intensive care, and medical 
 treatments, have transformed many of these fatal lesions into manageable chronic 
conditions [1].
Many more of these patients are surviving with this physiology than could have 
been contemplated 30 years ago and nowadays they seek medical attention for other 
causes different from their cardiovascular conditions that require surgical noncar-
diac procedures.
A normal biventricular cardiovascular system consists of a double circuit, pulmo-
nary and systemic, connected in series and powered by a double pump. Many com-
plex cardiac malformations are characterized by the existence of only one functional 
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ventricle. This single ventricle (SV) has to maintain both the systemic and the 
 pulmonary circulations, which at birth are not connected in series but in parallel [2].
Regardless of the exact nature of the connections, the completed circulation is 
often described as one having a single energy source, the systemic  ventricle [3].
The survival improvement of patients with univentricular physiology is due to 
the development of the staged palliation approach for complex congenital heart 
lesions not suitable for biventricular repair. The final Fontan stage results in the 
conversion of a parallel circulation, to a pulmonary and systemic circulation that is 
in series regardless of the underlying cardiac anatomy [2, 4]. Such lesions include 
hypoplastic left-heart syndrome (HLHS), tricuspid atresia, unbalanced atrioven-
tricular septal defects, double-inlet left ventricle, double-outlet right ventricle, and 
some forms of heterotaxy syndrome [5].
The objective of this chapter is to provide anesthesiologists the conceptual 
aspects applicable to the preoperative evaluation and perioperative management of 
patients with the unique Fontan physiology.
2. The Fontan patient
2.1 Staged palliation
First stage: The goals of initial palliation are to provide unobstructed systemic blood 
flow, well-balanced pulmonary and systemic circulations with controlled pulmonary 
blood flow, and unobstructed pulmonary and systemic venous return (including 
unrestricted atrial level mixing of venous returns). The elevated pulmonary vascular 
resistance (PVR) characteristic of the newborn period requires a staged approach to 
achieve these long-term goals that include normalization of the ventricular volume load 
and provision of normal systemic oxygen delivery. The success of a shunt is evaluated 
based on the relief of cyanosis, without a significant volume overload of the ventricle, 
and the induction of pulmonary growth without causing major changes to PVR. The 
systemic to pulmonary shunt is designed to last 4–6 months, sufficient time for the PVR 
to drop, allowing a partial cavopulmonary connection to be created safely (Figure 1).
Second stage: The superior cavopulmonary connection (SCPC, bidirectional Glenn 
or hemi-Fontan) is the surgical anastomosis of the superior vena cava (SVC) to the 
pulmonary artery (PA) and has a significant benefit on cardiac function. The second-
stage procedure diminish the volume load on the SV while maintaining systemic oxy-
gen delivery. Therefore, the ventricular work-load approximates that of the systemic 
ventricle in a biventricular circulation. One of the critical features of the second-stage 
procedure is the opportunity for the ventricle to have enough time for remodeling fol-
lowing the removal of the volume load prior to Fontan completion (Figure 2). In addi-
tion, this stage provides the opportunity to address other anatomic and physiologic 
abnormalities (including atrioventricular valve regurgitation, PA distortion) in the 
same surgery, optimizing the chances of a successful Fontan completion later on [4].
Third stage: In 1971, Francis Fontan and colleagues described a surgical tech-
nique for successful palliation of patients with tricuspid atresia [3]. Subsequently, 
this technique has been applied to treat most forms of functional SV. Typically, 
1–3 years after the second stage, the inferior vena cava (IVC) is connected surgically 
to the PA to complete the Fontan procedure [5].
There are three different types of Fontan palliation:
• The atriopulmonary connection (APC) consists of the right atrium connected 
directly to the PA. Although this surgical reconstruction is not performed 
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in modern practice, patients with APCs are presenting to the perioperative 
setting as adults. The Fontan procedure has been considerably modified since 
the description of a direct APC by Fontan. Several modifications were subse-
quently proposed in an effort to improve hemodynamic function and counter-
act progressive atrial dilation [6].
• The intracardiac total cavopulmonary connection, or lateral tunnel, consists of 
a SVC surgically connected directly to the right PA. IVC traverses through the 
atrium via a baffle directly to the PA.
Figure 1. 
Changes in PVR according to time and the appropriate age for performing stage palliation until completing 
the Fontan procedure for complex congenital heart disease that does not qualify for biventricular repair (PVR, 
pulmonary vascular resistance; SVR, systemic vascular resistance).
Figure 2. 
Changes in the preload according to time and the appropriate age for performing stage palliation until 




• The extracardiac cavopulmonary connection also consists of a direct anasto-
mosis of the SVC to the PA. However, an extracardiac conduit is used to route 
IVC blood directly to the PA without traversing the right atrium [5, 7].
Initially, adult survivors were mainly APC Fontan patients, but increasing 
numbers of both forms of TCPC Fontan patients now survive to adult life [7]. The 
extracardiac cavopulmonary connection is the main method employed currently in 
surgical centers.
2.2 Fontan anatomy
The systemic venous blood passively entering the pulmonary circulation 
through a total cavopulmonary anastomosis (TCPA). Blood bypasses the right 
atrium via a baffle or a conduit. Blood is oxygenated in the lungs and enters the 
pulmonary venous system reaching the left atrium. The right and left atrium now 
function as a common pulmonary venous atrium (CPVA). A single functional 
ventricle actively drives blood flow through the systemic arteries and capillaries, 
with systemic venous return passively entering the pulmonary circulation. The final 
Fontan stage results in the conversion of a parallel circulation to a pulmonary and 
systemic circulation that is in series [2, 5] (Figure 3).
2.3 Fontan physiology
By creating a TCPC, a new portal system is made. A portal system occurs when 
one capillary bed pools blood into another capillary bed through veins without 
passing through the heart.
The Fontan morphophysiology has two essential components. First, the presence 
of a SV pumping oxygenated blood to the systemic circulation, this ventricle can 
be either, a morphologic right or left depending on the type of CHD. The second 
Figure 3. 
Fontan anatomy. Shows how systemic venous blood passively enters the pulmonary artery (PA) circulation 
through a total cavopulmonary anastomosis (TCPA). Blood prevents the right atrium through a baffle or 
conduit. Blood is oxygenated in the lungs and enters the pulmonary venous (PV) system reaching the left 
atrium. The right and left atrium now function as a common pulmonary venous atrium (CPVA). A single 
functional ventricle (SFV) actively drives blood flow through the systemic arteries and capillaries, with a 
systemic venous return that passively enters the pulmonary circulation. The final stage of Fontan results in the 
conversion of a parallel circulation to a pulmonary and systemic circulation that is in series.
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component is that the systemic venous return will reach the pulmonary arterial 
system without direct influence of a pumping chamber [2, 5].
The driving force that maintains adequate blood flow and therefore cardiac 
output (CO), is the pressure difference between the central venous pressure (CVP) 
and the common atrial pressure (CAP), that is also known as the transpulmonary 
gradient, for it to be adequate requires a well-functioning SV, decrease afterload and 
sufficient preload [5] (Figure 4).
The Fontan operation produces a state of chronic low CO [8] and relies on 
nonpulsatile, passive flow of caval blood to the PAs. Because there is not a sub-
pulmonary ventricle, the circulation relies on low pulmonary pressures and low 
PVR. Forward flow through the pulmonary vasculature depends on a differential 
between the CVP and CAP [5]. Systemic venous hypertension is necessary to drive 
blood flow through the pulmonary vasculature with systemic venous pressure typi-
cally 5 mmHg higher than the pulmonary venous-atrial pressure [7].
2.4 Fenestration
An important feature of Fontan procedures, particularly lateral tunnel TCPC, 
is the fenestration or a surgically created small opening between the Fontan baffle 
pathway and the atrium. This 4-mm hole serves as a “pop-off” during times of 
high PVR and in essence maintains CO at the expense of a right-to-left shunt [5, 9] 
(Figure 4).
There is evidence including a prospective randomized trial that fenestration 
decreases the incidence of prolonged post-operative effusions, reduce post-opera-
tive lengths of hospital stay, and lessen the need for early reinterventions [4].
Figure 4. 
Fontan physiology. The right-to-left shunt through the fenestration allows the systemic venous blood to bypass 
the Fontan portal system, thereby increasing the single ventricle preload, increasing cardiac output, and 
decreasing systemic venous congestion at expense of cyanosis that results from a lower arterial oxygen saturation 
(SVC, superior vena cava; IVC, inferior vena cava; Ao, aorta; PA, pulmonary artery; SFV, single functional 
ventricle; CPVA, common pulmonary venous atrium).
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The right-to-left shunt through the fenestration allows the systemic venous 
blood to bypass the Fontan portal system, thereby increasing the SV preload, 
increasing CO, and decreasing systemic venous congestion at expense of cyanosis 
that results from a lower arterial oxygen saturation [9, 10].
Theoretically, the fenestration poses a risk for systemic embolic events and 
persistent cyanosis; however, the improved CO may have beneficial effects on oxy-
gen delivery and will also help to alleviate the congestion felt in upstream organs, 
particularly the liver [2, 5].
2.5 Fontan failure
Though life-saving, the univentricular Fontan circulation does not reproduce 
biventricular physiology and although generally well tolerated in childhood, it 
seems to be less well tolerated over time, affecting organ systems outside the heart. 
Fontan physiology can best be thought of as a man-made form of chronic heart 
failure (CHF) [10] and there are a significant number of medical complications 
associated with the long-term. There is evidence that circulatory failure rather than 
ventricular failure is most important in the failing Fontan.
Griffiths et al. evaluated the outcomes of failing Fontan patients listed for transplant 
and observed decreased survival in patients with preserved ventricular function com-
pared with those with impaired ventricular function [11]. The clinical deterioration can 
occur in the absence of ventricular dysfunction, suggesting that distinct mechanisms 
are contributive in comparison with heart failure patients from other etiologies.
Depiction of the hemodynamic profile of Fontan failure has been similar to 
traditional heart failure: elevated CVP, pulmonary capillary wedge pressure and 
systemic vascular resistance (SVR) with a low cardiac index (CI). Hebson et al. [12] 
evaluated the hemodynamic profile of a symptomatic adult Fontan (SAF) cohort 
with significant symptoms such as refractory edema, ascites, protein-losing enter-
opathy (PLE) or considerable exercise intolerance regardless of ventricular func-
tion. In the SAF patients, although CVP and pulmonary capillary wedge pressures 
were elevated, SVR index was low and CI was preserved even in the context of more 
severe symptoms. This suggests additional mechanisms influencing the hemody-
namics and contributing to the symptoms of Fontan failure.
Fontan patients cannot proportionately augment their CO above a certain 
threshold, thus potentiating renal hypoperfusion and leading to refractory symp-
toms [12] and in cases where the systemic ventricle functions poorly, the heart can 
make an already compromised circulation worse.
In a biventricular system, systolic performance will only affect CO at rest when 
the ventricular function is severely depressed. In a normal subject, CO is not 
influenced by an increase of PVR up to 5 Woods Units. In Fontan patients, PVR is 
the primary modulator of CO. Failing Fontans typically have a high PVR. The loss 
of pulsatile flow after TCPC affects the usual vasoreactivity of the pulmonary bed. 
Ideally the lung vessels should be slightly oversized with low resistance. However, 
more frequently the abnormal development may result in relative hypoplasia of the 
large vessels coupled with endothelial dysfunction.
In all Fontan patients, an increase in PVR is invariably associated with a decrease 
in CO. If PVR is low, a reasonable output is achieved in patients with normal or 
moderately depressed ventricular function. However, severely depressed ventricu-
lar function results in low output [2] (Figure 5).
Late Fontan failure might present gradually and insidiously over years. The 
nature of Fontan failure is heterogenous, it is likely that not all patients “fail” in 
the same way, and each patient should be evaluated individually when looking for 
underlying causes [12].
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The circulatory problem in Fontan is the limit in the preload created primarily 
by the damming effect of this neoportal system. The strategy is to maximize the 
efficiency of this system, which could have better outcomes than more traditional 
heart failure therapies [2].
The components that make up the Fontan system are critically important in the 
overall function of the Fontan circuit. These components include the venoarterial 
Fontan connection itself, PAs, pulmonary capillary network, pulmonary veins, 
and the venoatrial connection. Impairment at any level of this portal system will 
have profound consequences on the output of the Fontan circuit [2] (Figure 6). 
Impairments at any component level include, but are not limited to, stenosis, hypo-
plasia, distortion, vasoconstriction, pulmonary vascular disease, loss or exclusion 
Figure 5. 
Modulation of CO by PVR in normal and Fontan patients. In Fontan patients, PVR is the primary modulator 
of CO. If PVR is low, a reasonable CO is achieved in patients with normal or moderately depressed ventricular 
function. However, severely depressed ventricular function results in low CO (CO, cardiac output; PVR, 
pulmonary vascular resistance; LV, left ventricle).
Figure 6. 
The failing Fontan (PA, pulmonary artery; PV, pulmonary vein; AV, atrioventricular; SVR, systemic vascular 
resistance; SVC, superior vena cava; IVC, inferior vena cava; PLE, protein-losing enteropathy).
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of large vessels or microvessels, turbulence and flow collision, flow mismatch and 
obstruction by external compression [2].
Bypassing the pulmonary vasculature can partially reverse the restrictions to CO 
imposed by the neoportal system. A Fontan fenestration allows flow to bypass the 
neoportal system, which results in venous decongestion and increase in CO.
However, while a fenestration can increase overall output, it does so at the 
expense of diminished arterial oxygen saturation. Nevertheless, in the setting of 
a fenestration, the increase in CO can result in an increase in peripheral oxygen 
delivery even if the saturation is diminished.
The strategy to manage a failing Fontan starts by determining modifiable 
conditions and intervene if it is deem necessary. The first step is imaging, using 
transthoracic echocardiography (TTE) and cardiac magnetic resonance (CMR) to 
obtain a full image of the Fontan anatomy. Assessment of atrioventricular valve 
regurgitation could be difficult therefore the use of transesophageal echocardiogra-
phy (TEE) is needed sometimes. Catheter-based intervention is used if obstruction 
is identified. Surgical interventions are necessary in certain cases.
The goal of the management of the patient with Fontan physiology is to preserve 
symptom-free survival for as long as possible.
3. Preoperative evaluation of the Fontan patient
3.1 Perioperative risk stratification
Anesthesiologists outside of referral pediatric cardiovascular hospitals should 
be familiar with the anatomy, physiology, long-term manifestations and unique 
perioperative management of patients with Fontan palliation, and in the preopera-
tive anesthesia consultation it is of paramount importance to define if this group of 
patients have an increased perioperative risk.
Faraoni et al. investigated the post-operative outcomes in children with and without 
CHD undergoing noncardiac surgery [1]. This study was performed using data from 
the 2012 pediatric database of the American College of Surgeons National Surgical 
Quality Improvement Program (ACS NSQIP Pediatric). They included elective versus 
emergent surgery, and different surgical types (i.e., thoracic, neurological, orthopedic, 
general pediatric (including ear, nose, and throat), plastics and urogynecology).
Children with CHD were classified into three groups: minor, major and severe 
CHD, as defined in the ACS NSQIP database, based on residual lesion burden and 
cardiovascular functional status (Table 1).
This authors evaluated in the cohort of patients if the presence of major or 
severe CHD is associated with an increased risk of anesthesia and surgery. Of the 
51,008 children included in the database, 4520 children with CHD underwent non-
cardiac surgery. After propensity score matching, they included 2805 children with 
minor CHD, 1272 with major CHD, and 417 with severe CHD. The overall mortality 
was significantly higher in children presenting moderate (3.9%) and severe (8.2%) 
CHD compared with controls (1.2% and 1.7% respectively). No statistical differ-
ence was observed in children with minor CHD (1.5%) and their controls (1%).
The conclusions of the authors are children with major and severe CHD under-
going noncardiac surgery have an increased risk of mortality, and a higher inci-
dence of post-operative reintubation compared with matched controls undergoing 
comparable procedures. In the study, overall mortality in children with CHD was 
2.8% compared with 1.2% in children without CHD, corresponding to a 2.3-fold 
higher mortality rate in children with CHD. In conclusion, children with major or 
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severe CHD who undergo noncardiac surgery have an increased risk of mortality 
with a higher incidence of life-threatening postoperative outcomes compared with 
children without CHD [1].
Then Faraoni et al., developed a validation of a risk stratification score for 
children with CHD undergoing noncardiac surgery [13]. The objective of this study 
was to identify the predictors for in-hospital mortality, and to develop a risk strati-
fication score that could be used to help decision making and the development of 
perioperative management guidelines. This study was performed using data from 
the 2012, 2013, and 2014 pediatric databases of the ACS NSQIP and included all 
children with major or severe CHD as previously defined. They were able to identify 
eight predictors for in-hospital mortality in children with major and severe CHD 
undergoing noncardiac surgery: four were preoperative markers of critical illness 
(inotropic support, mechanical ventilation, preoperative cardiopulmonary resus-
citation (CPR) and acute or chronic kidney injury), the type of lesion (e.g., single 
ventricle physiology (SVP)) and the functional severity of heart disease (e.g., severe 
CHD). All of them were excellent predictors of in-hospital mortality (Table 2).
Children with SVP were identified to be at high risk for perioperative complica-
tions and at increased risk of in-hospital mortality regardless of their functional 
status. Although ACS NSQIP Pediatric database allows identification of patients 
with SVP, does not provide accurate information on their specific stage of 
 palliation [13].
The 2018 ACC/AHA guidelines for the management of adults with CHD 
(ACHD) stated that patients with ACHD may have greater operative risk than 
patients without ACHD. The guidelines recommend optimization before and close 
surveillance after invasive procedures regardless of the complexity of the anatomic 
defect or type of procedure. In patients with ACHD, especially those with complex 
disease (ACHD AP classification II and III) and/or whose disease has progressed 
(stages B, C, D), noncardiac surgical and interventional procedures should be per-
formed in a hospital with or in consultation with experts in ACHD when possible. 
Because the inability to access resources or urgent conditions may preclude transfer 
or timely consultation, collaboration with members of the multidisciplinary ACHD 
team may be helpful [14].
Minor CHD:
• Cardiac condition with or without medication and maintenance (e.g., atrial septal defect, small-to-
moderate ventricular septal defect with no symptoms)
• Repair of congenital heart defect with normal cardiovascular function and no medication
Major CHD:
• Repair of congenital heart defect with residual hemodynamic abnormality with or without medica-
tions (e.g., Tetralogy of Fallot with wide open pulmonary insufficiency, HLHS including stage 1 
repair)
Severe CHD:
• Uncorrected cyanotic heart disease
• Patients with any documented pulmonary hypertension
• Patients with ventricular dysfunction requiring medication
• Listed for heart transplant
CHD, congenital heart disease; HLHS, hypoplastic left-heart syndrome.
Table 1. 
Groups of children with CHD.
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3.2 Multisystem approach for Fontan patient evaluation
Even though mortality in patients with SVP who undergo staged palliation 
has decreased significantly over the past decades, Fontan physiology and its 
long-term complications (e.g., arrhythmias, circulatory failure, multi-organic 
compromise, etc.) continue to pose significant challenges in the management 
of children and adults requiring anesthesia for noncardiac surgical or invasive 
procedures.
The preoperative evaluation of the patient with Fontan physiology involves a 
thorough history and physical examination as well as review of recent cardiovas-
cular imaging studies, using a multisystem approach with attention to the unique 
characteristics of this patient population (Figure 7).
In the preoperative evaluation the anesthesiologist must define if the Fontan 
patient has a normal functioning or a failing Fontan, since it has important implica-
tions in the anesthetic management and in the perioperative care.
Medical history should focus on changes in health status, exercise capacity, 
hospital admissions, current medication and allergies. In addition to clinical exami-
nation, medical records, electrocardiography, chest X-ray, echocardiography, most 
recent catheterization, CMR imaging and laboratory data are invaluable to elucidate 
cardiac anatomy and the Fontan circuit, oxygen saturation, transpulmonary gradi-
ent and to assess ventricular function and valve regurgitation.
The physical exam of a well-functioning Fontan despite the univentricular 
pathology should be relatively unremarkable. The patient should be acyanotic, 
warm and well perfused. Precordial auscultation should be devoid of murmurs and 
peripheral arterial pulses are palpable. The arterial oxygen saturation is typically 
between 90% and 95% [5].
Failing Fontan physiology involves multiple organ systems: ventricular  
failure, hepatic disfunction, long lasting pleural effusions, pulmonary hyperten-
sion, PLE, plastic bronchitis. Symptoms indicative of a failing Fontan include 
dyspnea, fatigue, decline in exercise tolerance, weight gain or volume retention, 
palpitations, syncopal or pre-syncopal episodes, a new or worsening murmur, 
hepatomegaly, oxygen saturation below 90% and dyspnea [5]. Cardiomegaly and/
or pleural effusions may herald a failing Fontan.
3.2.1 Cardiovascular evaluation
3.2.1.1 Functional status and exercise capacity
At peak exercise, a normal subject with a biventricular circuit can increase his 
CO by a factor of 5. In a patient with Fontan physiology, there is not physiologic 
mechanisms to allow for a similar increase in CO because the maximal mean venous 
pressure rarely reaches 30 mmHg, there is inability to power blood through the pul-
monary vasculature and subsequent blood acceleration, and the reactivity of PVR is 
1. Critical illness: inotropic support, mechanical ventilation, preoperative CPR, acute or chronic 
kidney injury
2. SVP
3. Functional severity: major CHD and severe CHD
CPR, cardiopulmonary resuscitation; SVP, single ventricle physiology; CHD, congenital heart disease.
Table 2. 
Predictors of in-hospital mortality.
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attenuated or absent. These limitations combined, result in the diminished ability to 
augment CO in response to an increase in metabolic demand, therefore limiting the 
Fontan patient to perform exercise (Figure 8).
Under resting conditions, the CO of a Fontan patient is 70–80% of what it would 
normally be for age and body surface area. During physical activity the limitations 
of the Fontan circuit are substantially magnified; a small difference of CO at rest 
can become a much larger difference during activity. At the best Fontan, the output 
is mildly decreased at rest with moderate capacity to increase flow during moderate 
exercise. In the failing Fontan patient, the output is severely reduced at rest and 
barely augments during minimal exercise [2] (Figure 9).
Fontan patients have lived with less than ideal CO their entire lives and might 
not recognize symptoms or demonstrate overt manifestations of progressive decline 
in functional status until deterioration is quite advanced [6].
The New York Heart Association (NYHA) classification, originally established 
for patients with CHF, is now widely used in CHD. It represents a simple classifica-
tion of exercise intolerance based on subjective symptoms. NYHA class does stratify 
patients, distinguishing patients with mild impairment from those with moderate 
or severe impairment of objective exercise capacity and the presence and severity 
of symptoms signify a worse objective exercise capacity. In the study of Diller et al., 
ACHD patients had exercise capacities as poor as those of patients with acquired 
Figure 7. 
Multisystem approach for Fontan patient preoperative evaluation.
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CHF, even though the latter were much older [15]. Although NYHA class is used 
widely, the underlying criteria are subjective and the reproducibility is low.
In contrast to NYHA, cardiopulmonary exercise testing is the best way to assess 
exercise performance in ACHD patients, because it gives accurate, reproducible and 
quantifiable data on cardiac and respiratory performance, also allowing the assess-
ment of unexpected deterioration. Most Fontan patients have undergone two or 
three re-operations, and this can lead to the development of restrictive lung defects 
in many patients. This finding, in addition to the restrictions in augmentation of 
the CO on exercise, contribute to a reduction in the measured peak oxygen uptake 
(peak VO2), with average Fontan patients achieving a peak VO2 of 60–70% that 
of age/sex/size-matched controls [7]. Longitudinal studies of late adolescents and 
young adults demonstrate this point well; as patients progress to late adolescence 
Figure 9. 
Cardiac output in normal heart and the Fontan patient, during exercise and at rest. (CO, cardiac output).
Figure 8. 
CO and exercise level. At peak exercise, a normal subject with a biventricular circuit can increase his CO by 
a factor of 5. The Fontan patient has a diminished ability to augment CO in response to increased metabolic 
demand, and therefore limit the ability of a patient with a Fontan to perform exercise (CO, cardiac output; LV, 
left ventricle).
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and early adulthood, exercise capacity tends to continue to decline by about 2.6% 
predicted per year [9, 16]. In many forms of CHD the cutoff for the development of 
symptoms of heart failure is an exercise capacity of 45–50% of the predicted value. 
Assuming a starting point of 65% predicted for age and at the onset of puberty in 
a Fontan patients, and calculating a decline of 2.6% per year thereafter, the cutoff 
of 45% predicted can be expected to be reached at the end of the second decade of 
life [2] and as typically occurs in the third decade of life, hospitalization rates and 
symptoms increase significantly [6, 16, 17]. Cardiopulmonary exercise testing can 
objectively quantify exercise tolerance and help guided therapy, therefore, peak VO2 
is an essential component of a tailored exercise and activity program [6].
In the Mayo Clinic cohort [10], 80% of the patients after the Fontan operation 
rated their current health as excellent, and a similar percentage of patients thought 
that their physical status was improved. This is consistent with previously reported 
data suggesting that patients tend to perceive themselves as having a higher func-
tional status compared with control populations.
In the preoperative evaluation, it is important to recognize that NYHA class 
underestimates the true degree of exercise limitation in Fontan patients. It is likely 
that Fontan patients have made lifelong adaptations to their cardiovascular disease 
and its slow progression, so they are not aware of the true extent of their exercise 
intolerance and could consider themselves asymptomatic. The presence and sever-
ity of symptoms signify a worse objective exercise capacity in these patients [15].
3.2.1.2 Arrhythmias
Some factors contributing to arrhythmogenicity include systolic and diastolic 
dysfunction, atrioventricular valvular regurgitation, atrial enlargement, multiple 
cardiac procedures, myocardial fibrosis, APCs, intra-atrial tunnels and an abnormal 
array of atrial fibers. The incidence of late atrial tachyarrhythmias approaches 
50% in the adult population after Fontan palliation and often results in decreased 
exercise capacity, fatigue and congestive heart failure [5–7, 10].
In the Mayo Clinic cohort [10], the diagnosis of new clinical arrhythmias during 
long term follow-up was present in 44% of the patients. Freedom of arrhythmia at 
10, 20 and 30 years after the Fontan operation was 71%, 42% and 24% respectively. 
The majority of this patients had atrial fibrillation or flutter, and a smaller propor-
tion presented, atrial tachycardia, re-entrant supra ventricular tachycardia and 
ventricular tachycardia.
Sinus node dysfunction is common in all Fontan variants, with prevalence rates 
as high as 40%. Sinoatrial dysfunction and bradyarrhythmias may necessitate 
placement of a dual-chamber pacemaker or resynchronization therapy [5].
In general, many strategies have been employed to reduce the arrhythmia 
burden, including oral antiarrhythmics and catheter ablation. A catheter-based 
ablation strategy has a considerably lower success rate in Fontan patients compared 
with other forms of CHD, with recurrences or new arrhythmias in approximately 
50% within 4–5 years [6].
In the preoperative evaluation one should recognize the history of such arrhyth-
mias and history electrophysiological procedures.
3.2.2 Pulmonary evaluation
In the preoperative evaluation determine the patient’s saturation on room air, 
which in a well-functioning Fontan should be between 90% and 95%. In the case of 
desaturation, it is important elucidate the cause of hypoxemia (Table 3).
Aortic Valve Disease
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Persistent or recurrent pleural effusions can be a source of hypoxemia in Fontan 
patients. Systemic oxygen desaturation can also be found because of intrapulmo-
nary shunting due to arteriovenous malformations. The unequal distribution of 
hepatic blood flow to the pulmonary system is the most accepted etiology. Less 
hepatic blood flow to the pulmonary vasculature makes it more prone to developing 
arteriovenous malformations [5].
As pointed before, most Fontan patients have undergone at least two or three 
open chest procedures and may have undergone a thoracotomy that leads to a 
restrictive lung defect. Nearly half of all ACHD patients have lung disease with a 
primarily restrictive pattern, which represents an independent predictor for mortal-
ity [18]. The etiology is multifactorial: intrinsic causes of restrictive lung disease 
range from decrease in the pulmonary blood flow, development of arteriovenous 
malformations at the level of the lung and the long standing persistent abnormal 
physiology that contributes to the changes in the pulmonary vascular bed. Extrinsic 
causes are related to the multiple re-operations, congenital chest wall and spinal 
deformities, preexisting muscle weakness, all having an effect in the pulmonary 
mechanics. Other contributing factors as extended mechanical ventilation due to 
critical illness during childhood, chronic aspiration, acquire muscle weakness, and 
poor nutrition, can result in impaired pulmonary function [18].
Plastic bronchitis is a rare complication reported in less than 1–2% of Fontan 
patients. It is characterized by bronchial casts, with potential for airway obstruc-
tion. Segmental airway obstruction can result in regional atelectasis and hypox-
emia. Dyspnea, chronic cough, and recurrent expectoration of rubber airway casts 
are characteristic of this disorder. Plastic bronchitis can be life-threatening on 
presentation [6].
Another source of hypoxemia in Fontan patients include persistent right-to-left 
shunting. Maintaining adequate preload for the SV is challenging in the Fontan 
patient, and it relies on a number of “auto-regulatory” phenomena, including the 
development of veno-venous collateral vessels that pass from the systemic veins 
to the pulmonary venous circulation shunting deoxygenated blood directly into 
the oxygenated pulmonary venous system or the common atrium. The downside 
to maintaining an adequate preload and CO is the profound cyanosis that can be 
worsened by physical exertion (Figure 6).
The strategy employed in many centers is a catheter based embolization of these 
vessels. The impact on the symptoms or survival has not been determined, and further 
reduction in oxygen saturation post-procedure, suggest a high recurrence rate [5, 7].
Systemic-to-PA collaterals are a frequent finding in cyanotic Fontan patients. 
Left alone, these collateral vessels may result in pulmonary hypertension and failure 
of the Fontan circulation.
Low pulmonary venous saturation:
• Pleural effusions
• Pulmonary arteriovenous malformations
• Intrinsic lung disease
• Plastic bronchitis
Right-to-left shunt:




Common sources of hypoxemia in the Fontan patient.
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3.2.3 Hematologic evaluation
Hypercoagulability and hypocoagulability both are more prevalent in patients 
with Fontan physiology [18].
After the Fontan operation, patients have been reported to have numerous clot-
ting abnormalities including deficiencies of protein C, protein S and antithrombin 
III. Hypercoagulability combined with decreased CO, a nonpulsatile low flow state 
to the pulmonary circulation, a high incidence of atrial arrhythmias and the pres-
ence of prosthetic material, contribute to a higher risk for thrombus formation in 
the Fontan patient [9].
Some studies have reported a rate of thrombus formation of up to 20% in 
patients after a Fontan procedure and they are a source of significant morbid-
ity and mortality [5, 9]. The incidence of thromboemboli after the extracardiac 
cavopulmonary connection is estimated to be 7.1% at 10 years after Fontan 
completion. This can result in pulmonary emboli, systemic emboli through a 
patent fenestration and systemic thrombi in the atria, PA stump or rudimentary 
ventricle [9].
Approximately 10% of patients within the first 5 years after Fontan palliation, 
develop thrombotic occlusion of central veins, this can result in pulmonary emboli 
and in SVC obstruction. Clinicians should not assume patency or availability of 
venous access for central monitoring of the subclavian, internal jugular or femoral 
vessels. The anesthesiologist relies on cardiac catheterization reports and Doppler 
ultrasound to assess vascular patency of the venous and arterial tree [5]. Many 
patients are on anticoagulants or aspirin, especially those with thrombosis history 
or with a failing Fontan with any of the following manifestations: ventricular fail-
ure, hepatic disfunction, long lasting pleural effusions, pulmonary hypertension, 
PLE, and plastic bronchitis.
3.2.4 Neurologic evaluation
The reported incidence of stroke ranges from 3% to 20%. Cerebral vascular 
accidents have been reported in adult patients with Fontan physiology secondary to 
atrial arrhythmias, hematologic derangements and systemic embolic events [5].
3.2.5 Hepatic and gastrointestinal evaluation
Fontan physiology, in particular, with the multitude of insults from persistent 
congestive hepatopathy, hypoxia, and ischemic hepatitis, has a high incidence of 
liver dysfunction [18].
There is growing recognition of the deleterious effects of systemic venous 
hypertension on hepatic function and the development of fibrosis, cirrhosis and 
hepatocellular carcinoma.
PLE is a cardinal sign of failing Fontan palliation. Pleural effusions with 
associated decreases in oxygen saturation, peripheral edema, ascites, malabsorp-
tion and loss of immunoglobulins are consistent findings in patients with PLE. 
Hypoalbuminemia, decreased total protein and stool positive for alpha 1-antitryp-
sin confirm the diagnosis [5, 7].
In the Mayo Clinic cohort [10] was found that although the Fontan procedure 
has improved overall survival in patients with SV, various events impact long-term 
survival, including diagnosis of PLE. The overall incidence of PLE in this study was 
9%. Overall mortality in the PLE cohort was 72% during 7 + − 7.4 years of follow-





ACHD patients have a prevalence of renal dysfunction 18 to 35 fold higher com-
pared to the general population. Renal dysfunction is seen in 50% of Fontan patients, 
including a 15% presenting with severe reduction of glomerular filtration rate [19].
3.2.7 Imaging
Preoperatively the use of recent or previous imaging studies allows the proper 
assessment of the Fontan cardiac function, pathway and vascular anatomy.
Chest radiography can present with abnormalities consistent with a failing 
Fontan, including cardiomegaly, pleural effusion and pulmonary edema.
To evaluate systolic and diastolic ventricular function is important to perform 
a preoperative TTE or TEE, it also evaluates atrioventricular valve function, the 
presence of an open fenestration and detects intracardiac thrombi.
Cardiac catheterization evaluates the Fontan hemodynamics measuring CAP, 
CVP, ventricular end-diastolic pressure, sampling blood along the vessels and 
chambers to determine their saturations and, CI calculation with the Fick Method. 
A high preoperative CAP suggests poor ventricular function, atrioventricular valve 
dysfunction or the presence of aortopulmonary collaterals. Isolated high CVP with 
low CAP reflects increased PVR or an obstruction along the Fontan pathway.
Cardiac catheterization can also allow the measurement of pressure gradients of 
obstructive lesions in the vena cava, pulmonary vessels and across the atrial septal 
defect. It is also used to assess the presence of right-to-left shunts causing desatura-
tion as baffle leaks, fenestrations, decompressing veno-venous collateral vessels, 
pulmonary arteriovenous malformations and systemic to pulmonary collaterals. 
Catheter-based interventions may be required to alleviate obstruction in the Fontan 
pathway, for managing profound cyanosis or for stenting of branch PA stenosis or 
venous pathway obstruction [7].
CMR imaging is increasingly used in assessing anatomy, flow, and function in the 
Fontan patient without a pacemaker [5, 7]. It is used to asses Fontan pathway flow, it also 
assess pulmonary venous return to exclude obstruction. In addition it can provide with 
an accurate assessment of the ventricular function and assessment of the branch PAs, 
and in the ventricular outflow pathway it can exclude recoarctation or narrowing [7].
Urgent and emergent noncardiac surgeries or invasive procedures should not be 
delayed for sophisticated imaging in the preoperative evaluation, but the anesthesi-
ologist should be aware of the previous studies and the actual anatomy of the patient.
4. Intraoperative management
Although there are guidelines for the perioperative management of patients with 
CHD undergoing noncardiac surgery [14, 18, 20–22], these recommendations are 
based on experience and expert opinion. The diversity of structural malformations 
in CHD, each with specific physiologic perturbations, hemodynamic consequences, 
and functional limitations, makes the development of general guidelines for periop-
erative management challenging [13].
4.1 Hemodynamic monitoring
Standard American Society of Anesthesiologists (ASA) intraoperative monitoring 
is often adequate for patients with a well-functioning Fontan, particularly for proce-
dures in which minimal hemodynamic derangements or fluid shifts are expected.
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For the failing Fontan patient or well-functioning Fontan patient presenting 
for more complex surgical procedures, intra-arterial blood pressure monitoring is 
useful for beat-to-beat monitoring of blood pressure and blood sampling to asses 
sufficient systemic perfusion and adequate balance in oxygen delivery and con-
sumption by measuring laboratory values such as lactate levels and central venous 
oxygenation [5, 18].
Upper-extremity blood pressure (noninvasive and radial arterial catheters) 
should be measured in the arm opposite to a previous Blalock-Taussig shunt (sub-
clavian artery-to-PA) to avoid falsely low blood pressure measurements [5].
It should be noted that CVP actually reflects mean PA pressure (MPAP) in 
Fontan patients.
Intraoperative placement of transcutaneous defibrillator pads is prudent in 
patients with a history of arrhythmias [5].
4.2 Vascular access
Regarding vascular access, abnormal vascular anatomy of the initial CHD, post-
surgical changes, multiple vascular interventions, and prior thrombus formation 
can pose significant challenges when patients are in need of vascular access [5].
Even though upper central venous access is possible in patients with Fontan 
circulation, exact knowledge of vascular anatomy is crucial for venous cannula-
tion. Venous mapping can be highly valuable before any intervention, and access 
obtained by interventional radiologists under direct fluoroscopic guidance may be 
required. A graph depicting which vascular access is patent in a particular patient 
should be readily available to the care team in order to avoid difficulty in placing 
lines in an emergency [18].
Another consideration when obtaining and maintaining vascular access is the risk 
of paradoxic emboli in the presence of right-to-left or bidirectional shunting through 
the post-surgical fenestration. Entrained air and dislodged thrombotic or infectious 
material can lead to paradoxic emboli and to infarction of brain, gut, kidney, and 
other end organs [18]. Before the administration of intravenous fluids or medications, 
all air must be evacuated meticulously and filtered to avoid systemic air embolism and 
use of air filters can mitigate the risk of accidental air entrainment [5, 18].
It is recommended that central venous catheters be removed as soon as possible 
to avoid thrombotic complications [5].
4.3 Anesthetic goals
There are important anesthetic considerations for the patient with Fontan 
physiology.
4.3.1 Maintenance an optimal transpulmonary gradient
The mainstay of anesthetic management is to maintain an optimal transpulmo-
nary gradient in order to achieve an adequate pulmonary blood flow and CO. The 
Fontan (CVP = MPAP) is typically 10 to 15 mmHg with a transpulmonary gradient 
of 7 mmHg. It is helpful to determine CAP values from the preoperative catheteriza-
tion because the anesthesiologist will not monitor this value in the operating room.
4.3.2 Differential diagnosis of desaturation
The differential diagnosis of acute oxygen desaturation in the intraoperative 
period may include factors unique to the Fontan patient.
Aortic Valve Disease
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Right-to-left shunts become important causes of hypoxemia. Acute elevation 
of PVR may cause right-to-left shunting across a fenestration or a baffle leak with 
the consequent drop in the saturation of the patient. PVR may be decreased acutely 
with hyperventilation (pCO2 30 mmHg or pH 7.45) and increasing concentrations 
of oxygen. Usual sources of hypoxemia in the perioperative period such as endo-
bronchial intubation, bronchospasm, and atelectasis always should be considered.
4.3.3 Respiratory management
The circulatory arrangement of the Fontan amplifies the effects of respiratory 
mechanics upon venous return. Negative intra-thoracic pressure augments the ante-
grade flow from the SVC, IVC, and hepatic venous circulation into the pulmonary 
arterial tree. The work of breathing is a significant additional energy source to the 
circulation in these patients. Normal negative pressure inspiration has been shown 
to increase pulmonary blood flow in patients after the TCPC [3]. Physiologically 
there is a correlation between total hepatic venous flow and respiration. During 
inspiration there is marked increase in hepatic venous contribution to the total 
venous return, due to a dual effect on venous pressure and compression of the liver 
by diaphragmatic decent. The liver acts as a sump of blood which can be drawn 
upon during inspiration [3].
Magnetic resonance flow measurements have shown that approximately 30% 
of the CO can be directly attributed to the work of breathing in patients after the 
TCPC [3]. In Fontan patients, inspiration resulted in increased ventricular filling at 
rest and during exercise [23].
The opposite happens with positive pressure ventilation (PPV). It has long been 
known that increasing levels of positive end-expiratory pressure (PEEP) during PPV 
are adverse to the Fontan circulation. The available data suggests a linear relationship 
between mean airway pressure and CI in these patients: the higher the mean airway 
pressure, the lower CI [3]. This can be explained by the effect of lung volumes on 
PVR, since both over-distention and collapse of alveoli, result in increases in PVR.
The management of these patients should therefore be directed towards mini-
mizing mean airway pressure when these patients are being ventilated for cardiac 
and noncardiac procedures. Also, an early postoperative restoration of normal 
negative pressure ventilation can be beneficial in these patients.
Adjustments to minimize positive intra-thoracic pressure can be made using mini-
mal PEEP, smaller tidal volumes, pressure-regulated ventilatory modes, or spontane-
ous ventilation with minimal pressure support [18], and avoid prolonged Valsalva 
maneuvers. One should maintain these patients with the minimum mean airway 
pressure compatible with normal oxygenation and adequate alveolar ventilation.
A sound strategy when using PPV would be to adjust ventilatory parameters 
that allows to achieve the lowest mean airway pressure, moderate alkalosis (pH 7.45, 
pCO2 35 mmHg), and one that reduces the risk of atelectasis. Fontan patients have 
tolerated PPV with minimal hemodynamic effects as long as proper ventilatory 
settings are used. Furthermore, it has been proposed that monitored anesthesia care 
without adequate ventilation may be more detrimental than the physiologic effects 
of PPV per se [5].
4.3.4 Circulatory management
Fontan patients pose a particular clinical challenge for the anesthesiologist due 
to their abnormal physiology and high risk for adverse events. Pre-existing chronic 
end-organ dysfunction makes these patients susceptible to acute exacerbation or 
organ failure [18]. Information of baseline cardiac function and hemodynamics 
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from prior heart catheterizations can provide reference filling pressures to mini-
mize the risk of over-resuscitation or under-resuscitation.
Fontan physiology patients are very sensitive to changes in preload, and high 
PPV settings can exacerbate hemodynamic instability as was explained before. 
Acute hypovolemia or vasodilation during critical illness can result in significant 
hypotension.
The effect of vasoconstrictors in augmenting preload in Fontan physiology is 
unclear because the compliance of the venous capacity system is reduced, and also 
an increase in ventricular afterload, due to arterial vasoconstriction, can decrease 
forward flow [18]. Hypervolemia due to excessive fluid resuscitation or chronically 
in the failing Fontan, can result in a reduced CO due to a decreased pressure gradi-
ent between systemic arterial and venous capacity system. Global congestion can 
lead to impaired pulmonary blood flow and right-sided congestion with subsequent 
pulmonary edema, kidney and hepatic dysfunction.
Finding the optimal volume status that balances adequate preload, venous 
congestion and organ perfusion could be challenging and requires vigilance and 
significant experience with these complex pathophysiologic states. Defining the 
end point of fluid administration (Blood components, Crystalloids) should be a 
balance of the risks and benefits of resuscitation. It is important to have the baseline 
pressures, hemoglobin level, signs of inadequate oxygen delivery, and concurrent 
factors affecting hemodynamics in order to decide how much and which fluid 
requires a particular patient [18].
Universally important applicable components when managing hemodynamics 
in these patients include maintaining adequate heart rate and intrinsic sympathetic 
tone, avoiding increases in PVR, and limiting harm from elevated intra-thoracic or 
intra-abdominal pressures [18].
Risks associated with medical intervention especially adrenergic agents are 
exacerbation of arrhythmias.
Low-cardiac-output syndrome will manifest as hypotension, elevated CVP, 
metabolic and lactic acidosis, and low urine output in the intraoperative period. 
Pharmacologically improving ventricular compliance lowers the CAP and increases 
the transpulmonary gradient without raising CVP. Milrinone, with its lusitropic and 
pulmonary vasodilatory properties, is well suited for the Fontan patient. Because 
systolic performance is not generally the primary issue in the Fontan circulation, 
the role of inotropic agents is often limited, and lowering the SVR while maintain-
ing preload can be challenging. Inodilators increase the contractility of the SV, but 
may not result in clinically significant more CO. There may be a role for inotropes in 
the Fontan patient with significant ventricular dysfunction but in general the role of 
these agents is limited [2].
5. Conclusions
• Since prognosis of patients with univentricular heart has improved signifi-
cantly in recent decades, this has resulted in the general anesthesiologist 
being able to meet at some point in his professional practice with this type of 
patients, whether to perform a noncardiovascular diagnostic or therapeutic 
procedure or noncardiac surgery. Therefore, the anesthesiologist must have 
an appropriate knowledge of Fontan’s anatomy and physiology as well as those 
patients with failed Fontan in order to provide them with a correct preopera-
tive evaluation and an adequate intraoperative and postoperative management, 
and to obtain the best results, thus achieving a better survival and quality of 
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• The differentiation between a patient with Fontan palliation in a compensated 
state versus the failing Fontan patient is one of the goals of the preoperative 
evaluation since the latter has a higher perioperative risk.
• Fontan patients may present with a multisystemic compromise and this poses 
challenges in the intraoperative management of noncardiac surgical or invasive 
procedures.
• Causes of intraoperative hypoxemia may be different from a patient with 
biventricular physiology. Situations unique for the Fontan patient include 
right-to-left shunting through the fenestration and the presence of veno-
venous collateral vessels.
• There is evidence that circulatory failure rather than ventricular failure is most 
important in the Fontan patient. In the failing Fontan one should rule out any 
problem in the Fontan circuit.
• Finally, this chapter covers a series of information with the purpose of facilitat-
ing a timely and complete orientation of univentricular patients in the stage of 
Fontan palliation, since these imply a challenge in professional practice.
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